| abstract |
The invention cyclopenta [d] [1,2] - The oxazine derivatives and the novel compound-octanoic relates to a photo derivatives, and more particularly, cyclopenta [d] [1,2] has a novel structure Protein phosphatase (PPase) such as protein tyrosine phosphatase 1B (PTP1B), Prl-3, CD45, Leukocyte Antigen-Related (LAR), Cdc25A, Cdc25B, Cdc25C, Yop, PP1, and vaccina human-related (VHR). Because of its excellent pharmacological inhibitory activity, the novel compounds or their pharmaceutically acceptable salts can be used for autoimmune diseases, acute and chronic inflammation, type 1 and type 2 diabetes, impaired glucose tolerance, insulin resistance, obesity, cancer and malignancy. The present invention relates to a use for the treatment and prevention of diseases related to diseases. |